Syros Pharmaceuticals is a biopharmaceutical company that develops treatments for hematologic malignancies. Its lead products include Tamibarotene, SY-2101, and SY-5609, which are in various stages of clinical trials. The company also has research collaborations and license agreements with other companies. Syros Pharmaceuticals was founded in 2011 and is based in Cambridge, Massachusetts.